Top 50 Health Care VC Funds & Investors in Israel (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
OurCrowd
VC Fund
|
22 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $604k–$65M |
|
Israel Innovation Authority
VC Fund
|
20 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Artificial Intelligence, Biotechnology | $140k–$5M |
|
Pontifax
VC Fund
|
20 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.3M–$128M |
|
Trendlines Group
VC Fund
|
15 | Israel, Singapore, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical Device | $650k–$15M |
|
Accelmed
VC Fund
|
9 | Israel, United States | Series D, Series A | Health Care, Medical Device, Medical | $695k–$96M |
|
Firstime Venture Capital
VC Fund
|
9 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $500k–$21M |
|
aMoon Fund
VC Fund
|
9 | United States, Israel, France | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5.7M–$93M |
|
OrbiMed
VC Fund
|
9 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$151M |
|
Kli Capital
VC Fund
|
8 | United States, Israel, Mexico | Seed, Series A | Health Care, Software, Wellness | $1.6M–$25M |
|
Vertex Ventures Israel
VC Fund
|
8 | Israel, United States, Canada | Series A, Series B, Series C | Software, Information Technology, Artificial Intelligence | $3.5M–$100M |
|
Grove Ventures
VC Fund
|
7 | Israel, United States | Seed, Series A, Series B | Artificial Intelligence, Software, Machine Learning | $3.5M–$74M |
|
Lightspeed Venture Partners
VC Fund
|
7 | United States, India, Israel | Series A, Series B, Seed | Software, Information Technology, Artificial Intelligence | $2.5M–$125M |
|
Pitango VC
VC Fund
|
7 | Israel, United States, China | Series A, Series B, Series C | Software, Health Care, Information Technology | $4M–$100M |
|
Longevity Venture Partners
VC Fund
|
7 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical Device, Artificial Intelligence | $1.2M–$11M |
|
Triventures
VC Fund
|
7 | United States, Israel, Ireland | Series A, Series B | Health Care, Medical Device, Medical | $6M–$28M |
|
fresh.fund
VC Fund
|
6 | Israel, United States, Norway | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $300k–$21M |
|
ALIVE Israel HealthTech Fund
VC Fund
|
6 | Israel, United States | Series A, Series C, Series B | Health Care, Medical, Medical Device | $4.4M–$55M |
|
Elron Ventures
VC Fund
|
6 | Israel, United States, China | Seed, Series A | Information Technology, Software, Cyber Security | $1M–$17M |
|
Sapir Venture Partners
VC Fund
|
6 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Biotechnology, Machine Learning | $1.3M–$40M |
|
Terra Venture Partners
VC Fund
|
6 | Israel, United States | Seed, Series A, Series B | Software, Machine Learning, Artificial Intelligence | $1M–$30M |
|
Entrée Capital
VC Fund
|
6 | United States, Israel, United Kingdom | Seed, Series A, Series B | Software, FinTech, Financial Services | $1.4M–$60M |
|
Sarona Ventures
VC Fund
|
6 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Information Technology, SaaS | $100k–$25M |
|
SeedIL Ventures
VC Fund
|
6 | Israel, United States, United Kingdom | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $1.7M–$21M |
|
Docor International Management
VC Fund
|
6 | Israel, United States | Series C, Series A | Health Care, Biotechnology, 3D Technology | $13M–$22M |
|
HBL Hadasit Bio Holdings
VC Fund
|
5 | Israel | Series A, Series B | Biotechnology, Medical, Health Care | |
|
Agriline
VC Fund
|
5 | Israel | Seed, Series A | Health Care, Medical Device, Medical | $1.3M–$17M |
|
Integra Holdings
VC Fund
|
5 | Israel | Seed, Series B, Series F | Biotechnology, Pharmaceutical, Life Science | |
|
PipelBiz.com
VC Fund
|
5 | Israel, United States, United Kingdom | Equity Crowdfunding, Seed | Software, Health Care, Medical | $152k–$1M |
|
Arkin Holdings
VC Fund
|
5 | Israel, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $2M–$95M |
|
Clal Biotechnology Industries
VC Fund
|
5 | Israel, United States | Series A, Series B | Health Care, Biotechnology, Medical | $4M–$55M |
|
Johnson & Johnson Robotics and Digital Solutions
VC Fund
|
5 | United States, Israel, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $300k–$100M |
|
TAU Ventures
VC Fund
|
5 | Israel, United States | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Machine Learning | $1M–$28M |
|
J-Ventures
VC Fund
|
5 | United States, Israel | Series A, Seed, Pre-Seed | Software, Health Care, Machine Learning | $3M–$27M |
|
Maccabi Fund
VC Fund
|
5 | Israel, United States | Seed, Series A, Grant | Health Care, Medical Device, Artificial Intelligence | $1.5M–$15M |
|
Good Seed Ventures
VC Fund
|
4 | Germany, Israel, United States | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $25k–$21M |
|
GlenRock Israel
VC Fund
|
4 | Israel, United States | Seed, Series A, Series B | Software, Cyber Security, Health Care | $100k–$19M |
|
Edge Medical Ventures
VC Fund
|
4 | Israel | Seed, Venture - Series Unknown | Health Care, Medical, Medical Device | $2M–$11M |
|
10D
VC Fund
|
4 | Israel, United States | Seed, Series A, Series B | Software, Artificial Intelligence, Health Care | $6M–$96M |
|
Tal Ventures
VC Fund
|
4 | Israel, United States, Cyprus | Seed, Series A, Series B | Software, Artificial Intelligence, SaaS | $3M–$120M |
|
Takeda Ventures
VC Fund
|
4 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics | $10M–$130M |
|
Rimonci Capital
VC Fund
|
4 | Israel, France, United States | Series A, Seed, Series B | Health Care, Medical Device, Eyewear | $3.6M–$11M |
|
Connecticut Innovations
VC Fund
|
4 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software | $300k–$25M |
|
Jibe Ventures
VC Fund
|
4 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $4.5M–$56M |
|
The Chartered Group
VC Fund
|
4 | Israel | Series A, Private Equity | Biopharma, Agriculture, Health Care | |
|
Btomorrow Ventures
VC Fund
|
4 | United States, United Kingdom, India | Series A, Seed, Series B | Health Care, Wellness, Food and Beverage | |
|
NextLeap Ventures
VC Fund
|
4 | Israel, United States | Seed, Series A | Software, Machine Learning, Health Care | |
|
Sanara Ventures
VC Fund
|
4 | Israel | Seed, Series A | Health Care, Medical, Medical Device | $800k–$6M |
|
XTX Ventures
VC Fund
|
4 | United Kingdom, United States, Israel | Series A, Seed | Artificial Intelligence, Software, Machine Learning | |
|
New York Ventures
VC Fund
|
4 | United States, Canada, Israel | Seed, Series A, Series B | Health Care, Biotechnology, Software | $1.5M–$53M |
|
Nina Capital
VC Fund
|
4 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $573k–$21M |
| Access all 1105 VC funds in Israel Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 286
- Round size: Seed $604k–$10M; Series A $5.3M–$22M; Series B $7M–$65M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Oriient — Bringing the GPS revolution indoors with the most scalable and accessible solution for buildings. No Hardware, Cost Effective, and Highly Accurate.
- Sequentify — Sequentify provides a technology that is based on tools from the synthetic biology and AI software worlds for targeted DNA sequencing applications such as cancer diagnostics, carrier screening, COVID-19 surveillance and other applications.
- BetterSeeds — The company focuses on non-GMO genome editing using CRISPR-Cas9 for creating a novel breed of seeds and crop traits that address the 21st-century agriculture challenges. BetterSeeds provides advanced seeds enabling better crops for mechanized harvesting, extreme e climate resistance, higher calory and nutrient values, and more.
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Biotechnology
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 183
- Round size: Seed $500k–$5M; Grant $140k–$3.5M; Pre-Seed $150k–$2.1M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Q-Factor —
- GeoRank Studio — GeoRank Studio is a specialist SEO, Generative Engine Optimisation (GEO), and Reputation Management agency helping businesses across the UK, EU, and US gain visibility in both traditional and AI-powered search.As AI search engines including ChatGPT, Perplexity, and Google AI Overviews now answer a growing share of commercial queries without aclick, GeoRank Studio helps businesses adapt. We implement the technical and content changes needed to get brands cited in AI-generated answers — a discipline known as Generative Engine Optimisation or GEO.Our core services include technical SEO audits and full implementation, GEO optimisation including FAQPage schema markup, entity optimisation, and AI crawler configuration, reputation management including review removal from Google and Trustpilot, negative SERP suppression, and monthly AI citation tracking reports.GeoRank Studio was founded in 2022 and operates fully remotely, serving clients in professional services, SaaS, hospitality, luxury retail, and e-commerce. All packages include a 14-day money-back guarantee.Official Website: georankstudio.com
- Inspira Technologies — Inspira Technologies is an innovative Medical Technology Company focused on the acute respiratory care market. The ART, Inspira’s novel technology, can address the unmet need of providing acute respiratory treatment that prevents mechanical ventilation while patients are awake and breathing spontaneously.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 113
- Round size: Series A $6.3M–$110M; Series B $20M–$128M; Series C $12M–$101M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
- Graviton Bioscience — Curing Disease through Restored Homeostasis
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 69
- Round size: Seed $650k–$4.1M; Series A $2.3M–$15M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- IBI-Ag — IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 37
- Round size: Series A $695k–$24M; Series D $13M–$96M
- Lead/follow: 46% lead, 54% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Corvia Medical — Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009and headquartered in Andover, Massachusetts.
- UltraClear —
- GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Firstime Ventures is investing in companies who are building a sustainable & accessible future for all.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 86
- Round size: Seed $600k–$6M; Series A $500k–$10M; Series B $5M–$21M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $50M in 2017
Portfolio highlights
- Baibys — Baibys is a medical automated platform that provides AI and robotics-based autonomous sperm selection solutions for IVF.
- Remepy — Redefining combination therapy by fusing traditional pharmaceuticals with clinically validated app-delivered protocols in a single, regulated prescription.
- STAX Engineering, Inc. — The STAX mission is to help 1 billion people significantly through new technologies that promote health, sustainability, reduced environmental toxins, and reduced global warming.
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 77
- Round size: Series A $5.7M–$83M; Series B $22M–$93M; Series C $30M–$82M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 615
- Round size: Series A $10M–$140M; Series B $24M–$151M; Series C $15M–$131M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Avedro — Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking. Avedro recently completed its US‐based, multi-centered, Phase III studies of corneal cross-linking for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Outside the UnitedStates, Avedro has commercialized both VibeX and its KXL System for performing Lasik Xtra and accelerated cross-linking. Additionally, Avedro is developing the science of Thermo‐biomechanics for therapeutic medical applications. The Keraflex® refractive correction procedure is the first technology developed from the Thermo‐biomechanics platform and is a non‐invasive, incision‐less ophthalmic procedure for flattening the cornea without the removal of tissue. Keraflex offers the unique ability to induce refractive change without weakening the cornea’s biomechanical integrity, as happens with Lasik and other refractive correction procedures. Keraflex is commercially available outside of the United States.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases.
- EDDA Technology — EDDA Technology offers computer assistance to the patient care management cycle and enables early detection and diagnosis of diseases.
Kli Capital is a firm focused on investing in fearless entrepreneurs who are building foundational enterprise technologies and ubiquitous consumer brands. We partner with exceptional founders with unique insights, from inception through all phases of growth.
Show more...Investment focus
- Industry: Health Care, Software, Wellness
- Stage:Seed, Series A
- Geography: United States, Israel, Mexico
Investor stats
- Total investments: 91
- Round size: Seed $1.6M–$8M; Series A $2.2M–$25M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $50M in 2022
Portfolio highlights
- Prograd — ProGrad develops a credit risk assessment platform to connect financial institutions with third-level students looking for funding. Its platform includes Artificial Intelligence in credit scoring to lend responsibly to young customers with thin credit files based on future earning potential.The company was founded in 2020 and is headquartered inLondon, England.
- Longevity AI — Longevity AI helps health systems, primary care networks, and clinics deliver proactive and preventive care at scale. The platform gives clinicians a single, continuously updated view of each patient, built from longitudinal clinical, behavioral, and historical signals, so they can identify rising risk earlier, intervene before thresholds arecrossed, and support longer, healthier lives. Florence, the platform's intelligent clinical companion, surfaces these insights directly inside the EMR: prioritized, protocol-aligned, and without adding documentation burden. Florence also translates those same insights into calm, personalized guidance for patients, helping them build the daily habits that compound into better long-term health. Deployed with Clalit Health Services and live within U.S. primary care networks, Longevity AI is demonstrating ~20% improvements in preventive interventions. Headquartered in Tel Aviv and New York.
- Sequent — Sequent is a pioneering online voting platform that utilizes advanced cryptographic technology and an open-source development approach to ensure online elections are secure, transparent and 100% verifiable.
We partner early with global-minded entrepreneurs seeking to disrupt large markets
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, Canada
Investor stats
- Total investments: 182
- Round size: Series A $3.5M–$28M; Series B $4.7M–$35M; Series C $5.6M–$100M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $70M in 2018
Portfolio highlights
- Rylo — Nagish captions your phone calls and empowers you to talk using text or voice. It's fast, private, and free.
- Aternity — Unlocking the full potential of your digital experiences has never been more accessible. Illuminate, accelerate and fully leverage the full breadth of possibilities with Riverbed.
- Quantum Art — Quantum Art develops scalable, multi-core quantum computers with advanced trapped ion qubits and multi-qubit gates, accelerating breakthroughs in AI, finance, and materials science.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 71
- Round size: Seed $3.5M–$20M; Series A $8M–$50M; Series B $20M–$74M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $185M in 2022
Portfolio highlights
- NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
- LimitlessCNC — Limitless CNC is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM agent that works with NX-CAM to give industry-specific strategies and operations.
- Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations and trends.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, India, Israel
Investor stats
- Total investments: 1714
- Round size: Seed $2.5M–$30M; Series A $7M–$90M; Series B $13M–$125M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $2.4B in 2022
Portfolio highlights
- Brale — Combining the best of CeFi & DeFi.
- Razorpay — Online Payments India: Start Accepting Payments Instantly with Razorpay's Payment Suite, which Supports Netbanking, Credit Card & Debit Cards, UPI etc.
- Matillion — Enterprise level data integration tools built for the cloud. Harness your data into transformative business insights. Your data is your competitive edge.
Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, China
Investor stats
- Total investments: 282
- Round size: Series A $4M–$50M; Series B $7.5M–$44M; Series C $8.2M–$100M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $175M in 2023
Portfolio highlights
- Convizit — Convizit's AI automatically captures user actions, adds properties, and delivers this behavioral data directly into your analytics and marketing platforms.
- DriveNets — Providing the highest performance Ethernet-based back-end network solutions for AI infrastructures and open, high-scale routing solutions for service providers
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
Longevity Venture Partners is an early-stage venture capital firm committed to assisting entrepreneurs in the Silvertech, Healthcare, and Wellness sectors.
Show more...Investment focus
- Industry: Health Care, Medical Device, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 13
- Round size: Seed $4M–$11M; Pre-Seed $1.2M–$3.6M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- CustoMED — CustoMed transforms surgical planning and execution. It does this by converting medical imaging into 3D visualizations, planning procedures, and producing customized 3D-printed surgical solutions at scale in a matter of minutes, all while streamlining the process and providing surgical excellence.
- Sensifai Health — Powered by insights from wearables, Sensifai alerts inflammatory flares before symptoms enabling true early intervention.
- Urologic Health — Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and treatment of urinary disorders.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 60
- Round size: Series A $6M–$24M; Series B $6M–$28M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
- Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
- TailorMed — Moving Mountains for Patients
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Norway
Investor stats
- Total investments: 43
- Round size: Seed $2.2M–$12M; Pre-Seed $300k–$6M; Series A $11M–$21M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Kimba — Heal your mind, improve your sleep, and boost your health with Kimba's AI scent technology. Join Kimba and start sleeping better today!
- Wisio — Wisio lets social media creators and experts answer questions and requests from followers via paid interactions. The company’s platform empowers followers to gain exclusive access via personalized videos to their favorite creators. Wisio's flexible and easy-to-use platform is packed with features to help creators build deeper communitieswhile monetizing the creator - follower relationship. Thousands of them are already using it to help build their online reputation and business.Wisio's vision is to make everyone reachable.
- Shifters AI — Shifters AI is a software company that develops artificial intelligence and robotic solutions.
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series C, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 15
- Round size: Series A $4.4M–$17M; Series B $22M–$30M; Series C $30M–$55M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more...Investment focus
- Industry: Information Technology, Software, Cyber Security
- Stage:Seed, Series A
- Geography: Israel, United States, China
Investor stats
- Total investments: 65
- Round size: Seed $1.5M–$15M; Series A $1M–$17M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Cybersixgill — Cybersixgill is the leader in cyber threat intelligence enablement and enrichment. Their fully automated threat intelligence solutions help organizations fight cyber crime, detect phishing, data leaks, fraud and vulnerabilities as well as amplify incident response – in real-time. The Cybersixgill Investigative Portal empowers security teams withcontextual and actionable insights as well as the ability to conduct real-time investigations. Rich data feeds such as Darkfeed™ and DVE Score™ harness Cybersixgill’s unmatched intelligence collection capabilities and deliver real-time intel into organizations' existing security systems. Most recently, Cybersixgill introduced agility to threat intel with their CI/CP methodology (Continuous Investigation/Continuous Protection). Current customers include enterprises, financial services, MSSPs, governments and law enforcement entities.
- CartiHeal — Target improved outcomes in the treatment of knee cartilage and osteochondral defects with a porous, biocompatible and biodegradable off-the-shelf implant.
- Brainsgate — Established in 2000, BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases.BrainsGate's platform...
Early Stage VC
Show more...Investment focus
- Industry: Software, Biotechnology, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 20
- Round size: Seed $1.3M–$10M; Series A $10M–$40M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
- DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more...Investment focus
- Industry: Software, Machine Learning, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 41
- Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $31M in 2013
Portfolio highlights
- ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
- Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
- Intuition Robotics — The AI care companion robot for older adults
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves.We back founders with a partnership built on trust, fairness and real operating experience. Westand with founders through every challenge, and help them grow with clarity, resilience and purpose.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 268
- Round size: Seed $1.4M–$15M; Series A $5M–$30M; Series B $14M–$60M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $300M in 2022
Portfolio highlights
- Cypago — Enterprise-grade Cyber GRC Automation Platform Enterprise-grade Cyber GRC solution for any security and compliance standard, across hybrid and multi cloud environments
- Sensi AI — Clanz Technologies offers an audio-based system designed to support security in human interactions. The system works by connecting to devices that record audio. It analyzes audio data to find unusual sounds or patterns that may indicate incidents. When an anomaly is detected, the system sends alerts in real time. The service also providesinformation about conditions that can affect care quality, such as stress levels or lack of training. It can be used in places where monitoring human interaction is important for safety. The company offers a demo for organizations that want to use the system.
- IRP Systems — IRP Systems delivers high performance electric vehicle systems, EVVER e-powertrains and TrueDRIVE control software for fast integration.
Sarona Ventures is a venture capital firm based in Tel Aviv, Israel. The firm is a "people-first" investor, seeking founding teams with strong execution capabilities. The firm's investment scope focuses on enterprise software, and most of their deals concentrate on building the future of business with AI, helping companies operatemore efficiently, save money, and drive revenue.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $150k–$7.5M; Pre-Seed $100k–$1M; Series A $150k–$25M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $20M in 2019
Portfolio highlights
- WINN.AI — WINN.AI helps revenue teams run better sales calls and win more deals by automating admin work and guiding reps live, during the call.
- V-CHECK — V-Check is an information technology company that specializes in developing a portable payment app. Its software platform helps small businesses, shops, and startups in payment transactions. The company was founded in 2015 and headquartered in Tel Aviv, Israel.
- Visitt.io — Come to Visitt and see why CRE & multifamily property management, tenant experience and building operation teams all love our easy to use tools & tenant apps
We invest in the best Israeli founders. Boutique seed-stage VC with personalized support and international connections.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 32
- Round size: Seed $1.7M–$8M; Series A $2.2M–$21M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BlinqIO — Autonomously develop and maintain flawless automation code, combining Generative AI's power with human oversight for scalable testing solutions
- Quack — Get your team the power to resolve user issues right away.
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, 3D Technology
- Stage:Series C, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series C $13M–$22M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Check-Cap — Check-Cap Ltd. is merging with MBody AI to create a leading publicly traded embodied AI company powering autonomous workforces.
- Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B
- Geography: Israel
Investor stats
- Total investments: 9
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$7.5M; Series A $5M–$17M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Life Science
- Stage:Seed, Series B, Series F
- Geography: Israel
Investor stats
- Total investments: 8
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
PipelBiz enables companies to raise capital from an unlimited number of investors without the need of a prospectus
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Equity Crowdfunding, Seed
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 45
- Round size: Equity Crowdfunding $152k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
- Omnistream — Omnistream offers high-quality and user friendly app that produces professional video and production suit from your smartphone Omnistream empowers content creators, enabling anyone to produce high-quality and real-time video at an affordable and easy to use way
- Nina Medical Ltd. — NINA Medical advances innovations for non-invasive surgery, widening the reach of next-generation medicine.
Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 31
- Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $270M in 2021
Portfolio highlights
- Lendbuzz — Lendbuzz is an AI-based auto finance platform that helps consumers with thin or no credit history obtain financing when purchasing a car. Powered by machine learning and proprietary algorithms, Lendbuzz is able to better assess the creditworthiness of consumers with limited credit history, who are underserved by the traditional banks. By partneringwith auto dealerships, Lendbuzz is able to offer consumers attractive financing solutions and dealerships are able to close additional business opportunities and serve a more diversified client base. Lendbuzz is headquartered in Boston, Massachusetts and was founded in 2015.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 15
- Round size: Series A $4M–$55M; Series B $15M–$33M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- TytoCare — TytoCare offers the Home Smart Clinic - for accessible, high-quality primary care from home, with no compromises.
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Healthcare innovation wherever it originates.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 73
- Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- Manus Neurodynamica — Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
- Glyphic Biotechnologies — We sequence proteins. We have exciting updates coming soon... Contact us or sign up for updates below to be the first to know. Let's Chat. Partner. Collaborate. Team Up. Discuss. Talk. Co-Develop. Let's build something great and change the future of proteomics together. Send us a message! Subscribe to our updates!
TAU Ventures is an early-stage focused venture capital fund affiliated with Tel Aviv University, investing in the next generation of impactful home-grown technology companies. At the heart of the start-up nation, TAU Ventures invests the first capital into startups and is dedicated to helping them transform their ideas into global businesses.TAU Ventures cultivates an innovation ecosystem by combining the resources and global network of Tel Aviv University, strong industry connections, and a supportive home-base for founders. Together with its world-leading team of experienced mentors, TAU Ventures empowers startups in their critical, early steps. At its 1000 sq meter co-working office space located in Tel Aviv, the team works shoulder to shoulder with their portfolio companies, nurturing their growth by drawing on the strength of its innovation ecosystem on a daily basis.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 42
- Round size: Seed $1M–$5.3M; Series A $6M–$28M
- Lead/follow: 10% lead, 90% follow
- Last fund: Likely still investing — raised $50M in 2021
Portfolio highlights
- Deeto — Deeto provides an AI‑driven customer activation platform that automates sourcing, sharing customer testimonials, and reference engagement.
- Zenyard — Zenyard develops an AI agent platform focused on software reverse engineering. The platform automates repetitive manual tasks in analyzing binaries and decompiled code so security and research teams can focus on understanding behavior and intent. Zenyard supports reverse engineers by providing full-file context and workflow assistance. It targetsuse cases such as malware analysis, vulnerability research, and code auditing. The company serves technical teams that need to accelerate and standardize complex reverse engineering processes.
- XTEND — Explore cutting-edge military-grade tactical drones powered by AI, designed to enhance strategic capabilities and mission success in complex environments.
J- Ventures is a Silicon Valley based group of VC funds with over $60m under management. Backed by 400+ leading Investors ( 140+ Serial founders, 100+ VCs, 170+ Fortune 500 Executives) as LPs. Our active-LP venture fund brings the power of this connected & intellectual capital to add real value to the companies we invest in and create aremarkable difference by helping our founders grow and scale to markets quicker. Based in Silicon Valley with investors from 15 communities - Tel Aviv, NYC, LA, London, Miami, Boston, and more. Since 2016 the group made over 50 investments, 4 unicorns and over 10 exits.
Show more...Investment focus
- Industry: Software, Health Care, Machine Learning
- Stage:Series A, Seed, Pre-Seed
- Geography: United States, Israel
Investor stats
- Total investments: 74
- Round size: Seed $3M–$7.2M; Series A $7.7M–$27M
- Lead/follow: 3% lead, 97% follow
- Last fund: Likely still investing — raised $32M in 2023
Portfolio highlights
- Zenskar — Zenskar seamlessly manages complex subscription and usage based billing. Meter high throughput data, and automate revenue accounting, analytics & dunning.
- CopilotKit — CopilotKit is the full-stack framework for building user interactive agents and copilots. The company behind the AG-UI Protocol.
- RAAAM Memory Technologies Ltd. — RAAAM provides a unique on-chip memory technology that offers the highest-density embedded memory solution in any standard CMOS process.RAAAM develops a high-density memory technology that allows for up to 50% higher on-chip memory density with no cost, complexity, or performance-penalty.
Maccabi Fund is an investment fund.
Show more...Investment focus
- Industry: Health Care, Medical Device, Artificial Intelligence
- Stage:Seed, Series A, Grant
- Geography: Israel, United States
Investor stats
- Total investments: 8
- Round size: Seed $1.5M–$3.5M; Series A $1.5M–$15M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- AccuLine — AccuLine is a digital healthcare company, which was founded with the vision to saves the lives of millions of people worldwide. AccuLine is developing CORA—a smart, accurate, and easy to use exam for the early detection of coronary artery disease. The clinically validated CORA evaluates a patient's risk of having coronary artery diseasethrough advanced analysis and detection of two newly discovered biomarkers in the heart’s electrical activity. CORA’s early detection will assist in the prevention of sudden cardiac deaths, while lowering costs of cardiovascular related illness.
- Olive Diagnostics — It's About me (IAM) has developed a passive sensor mounted to the rim of the toilet that performs urinalysis every time the end-user urinates. The information is uploaded to a robust data science platform to track existing and progressing conditions. Real-time, actionable notifications will be sent to the end user for proactive medical ornutritional care. Ongoing biomarker tracking for hydration, Alcohol, Pregnancy, Ovulation, Keytones, etc. is used to develop a comprehensive personal user profile.The technology will also be used for pharma and CRO companies to track the usage of drugs. While drug compliance issues plague health care systems around the world, I AM's technology will provide a reliable and continuous solution for tracking when and how people take their medicine or clinical trial drug.Nonindustrial nations will now have home access to urine lab services.
- Rhino Federated Computing —
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, United States
Investor stats
- Total investments: 32
- Round size: Seed $25k–$7M; Series A $6.7M–$21M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.
Show more...Investment focus
- Industry: Software, Cyber Security, Health Care
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 33
- Round size: Seed $1M–$19M; Series A $1.5M–$9M; Series B $100k–$12M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Constru — Constru offers a breakthrough computer vision technology to superpower the engineering and project management teams onsite, monitoring every job, on every wall, throughout the construction process. The system collects and analyses photographic data and generates prescriptive insights to support business decisions and help the teams reliably delivertop-quality projects on time and on budget.
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
- MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
Edge Medical Ventures is a medical technology-focused venture studio and fund led by industry professionals with considerable operational experience.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Venture - Series Unknown
- Geography: Israel
Investor stats
- Total investments: 4
- Round size: Seed $2M–$11M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- PatenSee — PatenSee is a clinical-stage medical device company that has developed a contactless surveillance system designed to detect early developing asymptomatic vascular stenosis in hemodialysis patients.The company is seamlessly integrated with technology that employs cutting-edge, multi-modal imaging technologies and machine learning to detect earlyindications of vascular access stenosis and allow for preventative and economical intervention. This allows care teams to carry out interventions to safeguard the patient's hemodialysis lifeline, enhance quality of care, and extend life expectancy.PatenSee was established in 2019 in Or Yehuda, Central by Gal Goshen.
- Urologic Health — Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and treatment of urinary disorders.
- Synchrony Medical — Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment.
10D is a venture capital firm that seeks to invest in early-stage Seed and Series A rounds in digital health, fintech, insurance, computer vision, and artificial intelligence startups.The firm previously operated under the temporary name, Ofek Ventures. It pursues startups that disrupt markets by using deep technology, creating new businessmodels, and featuring entrepreneurial teams. 10D makes $1 million to $5 million in initial investments and follow-on investments of up to $10 million. Its portfolio companies include Seebo, the developer of artificial intelligence technologies for industrial plants; StuffThatWorks, a creator of a new healthcare database based on crowdsourcing; DayTwo, a provider of customized nutritional guidelines based on the gut microbiome for the purpose of lowering blood sugar levels; and additional investments.It was led by Yahal Zilka, Rotem Eldar, and Itay Rand in Tel Aviv, Israel.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 38
- Round size: Seed $6M–$12M; Series A $6M–$75M; Series B $9M–$96M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- SENAI — Master the Online Video Era. OVINT - Online Video Intelligence.
- Safebooks AI — Safebooks deploys AI agents that automate finance operations end to end. Reconciliation, validation, policy enforcement, workpapers, and more. Grounded in your actual data.
- Vortex Imaging — Vortex Imaging develops medical imaging devices.
TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, Cyprus
Investor stats
- Total investments: 56
- Round size: Seed $3M–$12M; Series A $5M–$25M; Series B $35M–$120M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Yuki — Reduce warehouse waste, prevent budget spikes, and keep queries fast across Snowflake and BigQuery. Yuki keeps AI workloads under control with budgets and priorities built in, optimizing in real time with zero engineer effort.
- Majestic Labs ai — Majestic Labs ai builds power-efficient AI servers for the largest and most advanced AI workloads.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 104
- Round size: Series A $10M–$58M; Series B $20M–$130M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
- Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
- Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A dedicated to China-Israel cross border investment.
Show more...Investment focus
- Industry: Health Care, Medical Device, Eyewear
- Stage:Series A, Seed, Series B
- Geography: Israel, France, United States
Investor stats
- Total investments: 10
- Round size: Seed $3.6M–$3.6M; Series A $6.6M–$11M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
- Laclarée — Laclarée develops a pair of adaptive eyeglasses for presbyopia. Its patented technology allows the eyeglasses to adapt in real-time to the scene viewed by the wearer. This major innovation will help milllions of people 45+ years, who are not satisfied with current solutions (progressive lenses, multiple pairs, etc...).
- BELKIN Vision — Imagine an efficient, non-contact glaucoma laser treatment able to alleviate IOP painlessly. Accessible Glaucoma Care at the touch of a button.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 259
- Round size: Seed $300k–$5.3M; Series A $2.4M–$25M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- 1touch.io — By continuously analyzing traffic and repository stores connected to your network, our network-based solution can detect all elements on the network that are storing, processing, and sharing personal data, both internally and externally. Whether structured or unstructured data, data in motion or at rest, and even data that is unknown to you,1touch.io can track it for you.
- Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
- LegiTime Technologies — Miami Embracing New Technology and Safety
Venture capital Israel | Seed fund | Pre seed fund | Founders fund
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 67
- Round size: Seed $4.5M–$20M; Series A $9M–$30M; Series B $25M–$56M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Sensi AI — Clanz Technologies offers an audio-based system designed to support security in human interactions. The system works by connecting to devices that record audio. It analyzes audio data to find unusual sounds or patterns that may indicate incidents. When an anomaly is detected, the system sends alerts in real time. The service also providesinformation about conditions that can affect care quality, such as stress levels or lack of training. It can be used in places where monitoring human interaction is important for safety. The company offers a demo for organizations that want to use the system.
- Arato — Arato.ai is an advanced AI agent simulation platform that helps organizations test, evaluate, and monitor generative LLM applications for production readiness. The system autonomously generates dynamic, real world user scenarios to execute thousands of multi turn conversations against AI agents to identify hallucinations, security threats, and UXdrifts.
- Notch — We are the first insurance designed specifically to cater the unique needs of the businesses and assets that make the digital economy. Get an instant quote today!
The Chartered Group is an investment platform.
Show more...Investment focus
- Industry: Biopharma, Agriculture, Health Care
- Stage:Series A, Private Equity
- Geography: Israel
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Zsquare — Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use.
- Pepticom Ltd. — Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators.
Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.
Show more...Investment focus
- Industry: Health Care, Wellness, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 44
- Lead/follow: no public data
Portfolio highlights
- Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
- Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
- PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
NextLeap Ventures offers investors the opportunity to invest in early stage, Israeli high-tech startups, selected through its unique, highly vetted process.
Show more...Investment focus
- Industry: Software, Machine Learning, Health Care
- Stage:Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 15
- Lead/follow: no public data
Portfolio highlights
- Carrar — A complete thermal management solution for electric vehicles dissipating heat faster and more efficiently than ever before. Thermal management for ev batteries.
- Cybord — Electronics components' quality, reliability, and highest level of traceability by leveraging visual AI and BigData
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
Sanara Ventures is an innovation-investment platform, elevating outstanding healthcare-technology companies, from early-stage to global market maturity. At Sanara, They share a vision of an integrated continuum of care supported by accessible advanced healthcare solutions for people around the world.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 8
- Round size: Seed $800k–$2.7M; Series A $4M–$6M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Panacea-ml — Panacea-ml revolutionizes clinical trial design with its data-driven, explainable-AI SaaS platform. Our cutting-edge technology addresses the primary causes of clinical development failure by identifying patient profiles that maximize therapeutic efficacy, minimize safety risks, and improve participant retention. Leveraging historical clinicaltrials and millions real-world patient health records, Panacea-ml's AI model enhances patient selection criteria, reduces cohort sizes, and uncovers novel marker-endpoint interrelations, surrogate markers, and causal relationships beyond simple statistical correlations.Our platform is a game-changer for the pharmaceutical industry, facilitating seamless collaboration across drug development, data science, and clinical teams. It accelerates drug development by generating precise sub-population profiles, refining patient selection criteria, and providing informed go/no-go decisions for each phase of development. Panacea-ml is versatile, supporting small sample sizes and various therapeutic domains, including rare diseases and early development stages.At Panacea-ml, we believe in empowering innovation and fostering collaboration to drive impactful outcomes. Our mission is to shorten time to market and enable early access to innovative treatments for patients worldwide.
- CVAid Medical — CVAid Medical develops an innovative AI based stroke detection technological platform.
- TailorMed — Moving Mountains for Patients
XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A, Seed
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 66
- Lead/follow: no public data
Portfolio highlights
- iGent — iGent AI focus on integrating advanced AI capabilities into the software development process.
- Verax AI — Seeks to be the leading provider of enterprise-grade trust solutions for Generative AI, enabling companies worldwide to build or adopt any Generative AI agent with confidence
- Prior Labs — Prior Labs is developing innovative foundation models that understand spreadsheets and databases.
New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the RegionalEconomic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 127
- Round size: Seed $1.5M–$7M; Series A $3M–$20M; Series B $2.5M–$53M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Adro — Designed to work when you arrive Spend and save like a local. Easy to use. No unfair fees.
- BQP — BosonQ Psi Pvt. Ltd. (BQP) is a state-of-the-art SaaS-based enterprise software venture leveraging the power of Quantum computing to speed up virtual simulations of Multiphysics and Computer-Aided Engineering (CAE) nature. BosonQ Psi is at the forefront of this quantum revolution. Our vision is to become the premier multiphysics simulation softwareusing quantum computing. Our world-class software suite will include computational science fields of fluid dynamics, structural dynamics, thermal, chemical, and aeroacoustics. With such an innovative product, we will revolutionize the computational world by enabling high-fidelity simulations that are impossible to solve with current computing technology. Further, this product will aid aerospace, automotive, energy, manufacturing, biotechnology, civil engineering, and astrophysics industries in saving millions of dollars by reducing long turnaround times of simulations used in the design process and give higher accuracy to make significant design changes for giving rise to the next generation of an electric car, eVTOL, skyscraper, or even Mars Rover.The possibility to harness the power of quantum computers is endless, and we at BQP thrive on pushing the boundaries of quantum computing technologies to serve our clients. We have made it our mission to bring these possibilities into the hands of every person - from a researcher to a scientist, from a professor to a student. Our name, BosonQ Psi, pays tribute to the great Indian physicist Dr. Satyendra Nath Bose, after whose name the elementary particle in quantum mechanics, Boson, was named and further incorporates the fundamental quantity that describes the state of the quantum particle - Psi, thus symbolizing the company's fundamental goal to contribute in India's goal to be the leader in the Quantum realm and also become a global leader in Quantum paradigm shift in coming years.
- CryoBio — CryoBio is an agricultural biotech company that provides biological solutions that allow crops to withstand sub-zero temperatures without damage.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 89
- Round size: Seed $2M–$6.3M; Pre-Seed $573k–$2.4M; Series A $5M–$21M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Navidence — Navidence provides a transformative Real World Evidence (RWE) Design platform that enables organizations to efficiently adapt to the ever-increasing ecosystem of Real World Data (RWD) sources. The company unlocks the power of Computable Operational Definitions (CODefs) for RWE Design and RWD Assessment. Navidence's RWE Sherpa platform offerstools to streamline the process of defining an RWE study's data, making it easier for researchers to conduct their studies in the age of data.
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
Health Care VC funding in Israel at a glance
Stats across 1.2k deals from 1.1k investors.
Access all 1105 VC funds in Israel Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 1105 VC funds investing in Israel Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!